General Information of Drug Off-Target (DOT) (ID: OTA1KTRN)

DOT Name Ubiquinol-cytochrome c reductase complex assembly factor 2
Synonyms Breast cancer-associated protein SGA-81M; Mitochondrial nucleoid factor 1; Mitochondrial protein M19
Gene Name UQCC2
Related Disease
Mitochondrial complex III deficiency ( )
Mitochondrial complex III deficiency nuclear type 7 ( )
UniProt ID
UQCC2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF20180
Sequence
MAASRYRRFLKLCEEWPVDETKRGRDLGAYLRQRVAQAFREGENTQVAEPEACDQMYESL
ARLHSNYYKHKYPRPRDTSFSGLSLEEYKLILSTDTLEELKEIDKGMWKKLQEKFAPKGP
EEDHKA
Function
Required for the assembly of the ubiquinol-cytochrome c reductase complex (mitochondrial respiratory chain complex III or cytochrome b-c1 complex). Plays a role in the modulation of respiratory chain activities such as oxygen consumption and ATP production and via its modulation of the respiratory chain activity can regulate skeletal muscle differentiation and insulin secretion by pancreatic beta-cells. Involved in cytochrome b translation and/or stability.
Tissue Specificity Pancreas, skeletal muscle, kidney, liver and heart.

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Mitochondrial complex III deficiency DISSUPJ6 Supportive Autosomal recessive [1]
Mitochondrial complex III deficiency nuclear type 7 DIS90707 Limited Unknown [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [2]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [3]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [4]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [5]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [6]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [7]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [6]
Panobinostat DM58WKG Approved Panobinostat decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [8]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [9]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [11]
Coumestrol DM40TBU Investigative Coumestrol increases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [12]
[3H]methyltrienolone DMTSGOW Investigative [3H]methyltrienolone increases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [13]
Okadaic acid DM47CO1 Investigative Okadaic acid decreases the expression of Ubiquinol-cytochrome c reductase complex assembly factor 2. [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Ubiquinol-cytochrome c reductase complex assembly factor 2. [10]
------------------------------------------------------------------------------------

References

1 Mutations in the UQCC1-interacting protein, UQCC2, cause human complex III deficiency associated with perturbed cytochrome b protein expression. PLoS Genet. 2013;9(12):e1004034. doi: 10.1371/journal.pgen.1004034. Epub 2013 Dec 26.
2 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
3 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
6 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
7 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
8 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
9 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
12 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
13 Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics. 2006 Sep 29;7:246. doi: 10.1186/1471-2164-7-246.
14 The marine toxin okadaic acid induces alterations in the expression level of cancer-related genes in human neuronal cells. Ecotoxicol Environ Saf. 2013 Jun;92:303-11. doi: 10.1016/j.ecoenv.2013.03.009. Epub 2013 Apr 3.